The Lancet in conversation with

Ein Podcast von The Lancet Group - Freitags

Freitags

Kategorien:

656 Folgen

  1. Nusrat Husain, Farah Lunat, and Fehmida Motala on postnatal depression in British south Asian women (the ROSHNI-2 trial)

    Vom: 31.10.2024
  2. Rasha Al-Lamee and Shayna Chotai on ESC 2024 highlights

    Vom: 10.10.2024
  3. Dr Oriol Mitjà and Dr Hypolite Muhindo Mavoko on mpox

    Vom: 5.9.2024
  4. Natasha Pocovi on the prevention of low back pain recurrence

    Vom: 8.8.2024
  5. Prasad Kulkarni on a vaccine against typhoid and paratyphoid

    Vom: 2.5.2024
  6. Patricia Campbell and Frans Rutten on heart failure with preserved ejection fraction

    Vom: 28.3.2024
  7. Lene Seidler on umbilical cord management at preterm birth

    Vom: 21.12.2023
  8. Emily Chew on the future of treatments for geographic atrophy

    Vom: 26.10.2023
  9. Simon Kyle on a new effective treatment for insomnia

    Vom: 31.8.2023
  10. Verna Vanderpuye and Isabelle Soerjomataram on International Women's Day and cancer

    Vom: 8.3.2022
  11. Nick James on the STAMPEDE trial

    Vom: 23.12.2021
  12. Jie Qiao (in Chinese) on reproductive health in China

    Vom: 2.6.2021
  13. Jie Qiao (in English) on reproductive health in China

    Vom: 2.6.2021
  14. Siobhan Quenby & Arri Coomarasamy on miscarriage

    Vom: 26.4.2021
  15. Muir Gray

    Vom: 25.2.2021
  16. Mary Bassett

    Vom: 11.2.2021
  17. Richard Horton on the Oxford vaccine phase 3 trial

    Vom: 8.12.2020
  18. Renee Salas

    Vom: 2.12.2020
  19. Rafael Lozano and Margaret Kruk

    Vom: 2.9.2020
  20. Richard Horton

    Vom: 20.7.2020

1 / 33

Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.

Visit the podcast's native language site